StockWatch
·
Medical/Dental Instruments
Business UpdateJun 16, 2026, 07:00 AM

Nephros Ultrafiltration Addresses EPA's Microplastic Priority

AI Summary

Nephros, Inc. highlighted its ultrafiltration technology's ability to effectively capture microplastics and nanoplastics, reinforcing its leadership in water quality challenges. This follows the U.S. EPA's April 2026 decision to include microplastics as a priority contaminant group under the Safe Drinking Water Act's draft Contaminant Candidate List (CCL 6). The company's filters, with pore sizes as small as 5 nanometers, are designed to exclude particles that conventional filtration technologies might miss, including bacteria and viruses.

Key Highlights

  • Nephros's ultrafiltration technology effectively captures microplastics and nanoplastics.
  • Follows U.S. EPA's April 2026 decision to list microplastics as a priority contaminant.
  • EPA's draft Contaminant Candidate List (CCL 6) highlights growing regulatory attention.
  • Nephros filters have pore sizes as small as 5 nanometers, below plastic thresholds.
  • Technology retains microplastics (1µm-5mm), nanoplastics (<1µm), bacteria, and viruses.
  • CEO Robert Banks states technology aligns with emerging concerns, differentiating Nephros.
  • Company sees a market shift to proactive, precision-based water quality management.